Showing results (621-630 of 634) with videos related to
Sort By:
Pageof 64
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2022
Oxaliplatin (3 months <i>v</i> 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07Seung Tae Kim, Sun Young Kim, Jeeyun Lee, et al.Cancer Research and Treatment|November 7, 2023
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort StudySongji Choi, Seyoung Seo, Ju Hyun Lee, et al.Molecular Medicine Reports|September 8, 2016
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cellsEun Kyoung Choi, Seung-Mi Kim, Seung-Woo Hong, et al.The Oncologist|February 18, 2017
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric CancerJi-Won Kim, Keun-Wook Lee, Kyu-Pyo Kim, et al.Nature Communications|December 8, 2018
Neural network analysis of sleep stages enables efficient diagnosis of narcolepsyJens B Stephansen, Alexander N Olesen, Mads Olsen, et al.Cancer Medicine|December 10, 2021
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter studyJwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, et al.Biochemical and Biophysical Research Communications|May 25, 2020
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLCDong Min Kim, Mi Jin Kim, Jai-Hee Moon, et al.The New England Journal of Medicine|October 1, 2019
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E-Mutated Colorectal CancerScott Kopetz, Axel Grothey, Rona Yaeger, et al.Cancer Research and Treatment|April 26, 2018
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer PatientsSe-Hoon Lee, Boram Lee, Joon Ho Shim, et al.Pageof 64